Nektar Therapeutics (NKTR) Earnings History
Annual and quarterly earnings data from 1994 to 2025
Loading earnings history...
NKTR EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NKTR Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 100.0% | -236.8% | -297.1% |
| 2024 | 68.8% | -106.9% | -120.9% |
| 2023 | 59.3% | -152.5% | -306.3% |
| 2022 | 76.5% | -261.0% | -400.0% |
| 2021 | 75.6% | -437.8% | -514.0% |
Download Data
Export NKTR earnings history in CSV or JSON format
Free sign-in required to download data
Nektar Therapeutics (NKTR) Earnings Overview
As of May 8, 2026, Nektar Therapeutics (NKTR) reported trailing twelve-month net income of -$164M, reflecting -12.1% year-over-year growth. The company earned $-8.08 per diluted share over the past four quarters, with a net profit margin of -297.1%.
Looking at the long-term picture, NKTR's historical earnings data spans multiple years. The company achieved its highest annual net income of $681M in fiscal 2018.
Nektar Therapeutics is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including HALO ($317M net income, 22.7% margin), ARWR (-$301M net income, -0.2% margin), ALNY ($577M net income, 8.4% margin), NKTR has room to improve margins relative to the peer group. Compare NKTR vs HALO →
NKTR Earnings vs Peers
Earnings metrics vs comparable public companies
NKTR Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$164M | -37.9% | -$131M | $-9.73 | -297.1% | -236.8% |
| 2024 | -$119M | +56.9% | -$105M | $-8.68 | -120.9% | -106.9% |
| 2023 | -$276M | +25.0% | -$137M | $-21.79 | -306.3% | -152.5% |
| 2022 | -$368M | +29.7% | -$240M | $-29.51 | -400.0% | -261.0% |
| 2021 | -$524M | -17.9% | -$446M | $-42.90 | -514.0% | -437.8% |
| 2020 | -$444M | -0.9% | -$380M | $-37.33 | -290.6% | -248.5% |
| 2019 | -$441M | -164.7% | -$440M | $-37.80 | -384.5% | -383.9% |
| 2018 | $681M | +804.6% | $688M | $56.70 | 57.1% | 57.6% |
| 2017 | -$97M | +37.0% | -$60M | $-9.30 | -31.4% | -19.4% |
| 2016 | -$154M | -89.1% | -$113M | $-16.50 | -92.8% | -68.2% |
See NKTR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NKTR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NKTR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNKTR — Frequently Asked Questions
Quick answers to the most common questions about buying NKTR stock.
Is NKTR growing earnings?
NKTR EPS fell to $-8.08, with earnings declining -12.1%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-164M.
What are NKTR's profit margins?
Nektar Therapeutics net margin is -297.1%, with operating margin at -236.8%. Below-average margins reflect competitive or cost pressures.
How consistent are NKTR's earnings?
NKTR earnings data spans 1994-2025. The declining earnings trend is -12.1% YoY. Historical data enables comparison across business cycles.